Venetoclax

Name: Venetoclax
Availability: venetoclax-232195.html

Category:Active Pharmaceutical Ingredients > Other Active Pharmaceutical Ingredients
Product Name:Venetoclax
CAS No.:1257044-40-8
Standard:In-house Standards
Price(USD):0.00
Company:Quanzhou Fortune Biopharma Co.,Ltd.

Send Inquiry

Favorites

Similar Products

Propantheline Bromide

carbomer 974P

Coenzyme Q10

Refined Fish Oil

Black Currant Extract

Hydrocortisone

Basic Info

Grade: Pharmaceutical Grade

Factory Location: QUANZHOU

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Sample Provided: no

Venetoclax is a new type of anticancer drug, a Bcl-2 inhibitor developed by the American pharmaceutical company AbbVie, which is effective against cancer and produces less than current drugs. The side effects of this study were mainly done by researchers in the United States and Australia, and the results of the research were published in the international journal Nature Medicine.

Indication: CLL(Chronic Lymphocytic Leukemia)

All the products under the patent are only for R&D use.

Patent from AbbVie, expiry date(The U.S):Jun.27, 2031.

Send your message to this supplier

From:
To:
Quanzhou Fortune Biopharma Co.,Ltd.
Send a Copy to this Email
Message:
Upload Images / Files
- Supports jpg, jpeg, png,
gif, pdf, doc, docx,
xls, xlsx, txt, rar and zip
- Max upload 3 files;
Max total size: 3MB
(0/3)

Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now
Verification:

Venetoclax

You may like